UC Davis Health, California, United States
Disclosure information not submitted.
O28 - Synergistic In Vivo Therapy Using Bioengineered microRNA and Chemotherapy for High-Risk Neuroblastoma
Thursday, October 9, 202510:00 AM - 11:00 AM PDT